AstraZeneca: Arthritis, Rheumatoid trials
The registry lists 49 Arthritis, Rheumatoid studies with AstraZeneca as lead sponsor. 4 are open to participants now and 21 have results posted.
Phase 1 23Phase 2 17Phase 3 6No phase 4(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- A Study of AZD0120 in Autoimmune DiseasesRecruitingNCT07295847Phase 1/2
- A Study to Investigate Efficacy and Safety of AZD1163 in Participants With Rheumatoid ArthritisRecruitingNCT07276581Phase 2
- Study Evaluating Safety, Tolerability, PK/PD of Surovatamig in Adult RA or SLE ParticipantsRecruitingNCT07201558Phase 1
- A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD5492 in Adult Participants With Systemic Lupus Erythematosus or Idiopathic Inflammatory Myopathies or Rheumatoid Arthritis.RecruitingNCT06916806Phase 1
- Early Phase Study to Assess Efficacy and Safety of AZD9567 Versus Prednisolone in Patients With Rheumatoid ArthritisCompletedNCT03368235Phase 2Results posted
- A Single Ascending Dose Study To Assess The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of AZD9567.CompletedNCT02512575Phase 1Results posted
- ACP-196 Versus Placebo in Subjects With Rheumatoid Arthritis on Background MethotrexateCompletedNCT02387762Phase 2Results posted
- Randomised Double-Blind, Placebo-Controlled, Parallel Group Study in Patients With Active Rheumatoid Arthritis:Magnetic Resonance Imaging Sub-StudyTerminatedNCT02092961Phase 2Results posted
- A Study of Mavrilimumab Versus Anti Tumor Necrosis Factor in Subjects With Rheumatoid ArthritisCompletedNCT01715896Phase 2Results posted
- A Long Term Safety Study of Mavrilimumab in Adult Subjects With Rheumatoid ArthritisTerminatedNCT01712399Phase 2Results posted
- A Study of Mavrilimumab in Subjects With Moderate-to-Severe Rheumatoid ArthritisCompletedNCT01706926Phase 2Results posted
- A Long Term Study to Assess the Safety of Fostamatinib in Patients in Asia With Rheumatoid ArthritisTerminatedNCT01640054Phase 2Results posted
- Evaluation of Safety and Effectiveness of Fostamatinib Compared to Placebo in Patients in Asia With Rheumatoid ArthritisTerminatedNCT01569074Phase 2Results posted
- Study of the Effect of Fostamatinib Twice Daily on Blood Pressure in Patients With Rheumatoid ArthritisCompletedNCT01563978Phase 2Results posted
- Evaluation of Efficacy and Safety of Fostamatinib Monotherapy Compared With Adalimumab Monotherapy in Patients With Rheumatoid Arthritis (RA)TerminatedNCT01264770Phase 2Results posted
- Evaluation of Long-term Safety and Effectiveness of Fostamatinib in the Treatment of Rheumatoid Arthritis (RA)TerminatedNCT01242514Phase 3Results posted
- Evaluation of Effectiveness of Two Dosing Regimens of Fostamatinib Compared to Placebo in Patients With Rheumatoid Arthritis (RA) Who Are Taking Methotrexate and Have Had Inadequate Response to Single TNF-alpha AntagonistCompletedNCT01197755Phase 3Results posted
- Evaluation of Effectiveness of Two Dosing Regimens of Fostamatinib Compared to Placebo in Patients With Rheumatoid Arthritis (RA) Who Are Taking Disease Modifying Anti-rheumatic Drug (DMARD) But Not Responding.CompletedNCT01197534Phase 3Results posted
- Evaluation of Effectiveness of Two Dosing Regimens of Fostamatinib Compared to Placebo in Patients With Rheumatoid Arthritis (RA) Who Are Taking Methotrexate But Not Responding.CompletedNCT01197521Phase 3Results posted
- A Study to Evaluate the Efficacy and Safety of CAM-3001 (Drug) in Subjects With Rheumatoid ArthritisCompletedNCT01050998Phase 2Results posted
- Open-Label, Multicenter Extension Study for Patients Completing Treatment Phase of a Rigel-Sponsored R935788 StudiesTerminatedNCT00805467Phase 2Results posted
- A Proof of Concept and Dose Ranging Study in Patients With Rheumatoid ArthritisCompletedNCT00713544Phase 2Results posted
- Long Term Study to Investigate the Efficacy & Safety of D961H (Esomeprazole) for the Prevention of NSAIDs-induced UlcerCompletedNCT00595517Phase 3Results posted
- Comparative Efficacy & Safety Study of Esomeprazole Versus Placebo for the Prevention of Gastric and Duodenal Ulcers With NSAIDCompletedNCT00542789Phase 3Results posted
- A 6-month Randomised, Double-blind, Open Arm Comparator, Phase IIb, With AZD9056, in Patients With Rheumatoid Arthritis (RA)CompletedNCT00520572Phase 2Results posted
- A Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics of Subcutaneous AZD6912 in Healthy ParticipantsCompletedNCT06115967Phase 1
- A Placebo-controlled Safety and Tolerability Study of Intravenous (IV) and Subcutaneous (SC) AZD1163 in Healthy VolunteersCompletedNCT06103877Phase 1
- A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Ascending Doses of AZD9567.CompletedNCT02760316Phase 1
- Assess Safety, Tolerability, Pharmacokinetics and Clinical Activity of AMP-110 in Subjects With Rheumatoid ArthritisCompletedNCT02277574Phase 1
- A Double-blind, Placebo-controlled, Single-dose Study to Evaluate the PK, IM, and Safety in Japanese SubjectsCompletedNCT02213315Phase 1
- Study to Assess the Safety, Tolerability, and Pharmacokinetics of AMP-110 in Subjects With Rheumatoid ArthritisCompletedNCT01878123Phase 1
- Assess the Pharmacokinetics of Rosuvastatin and Simvastatin When Administered Alone or in Combination With FostamatinibCompletedNCT01725230Phase 1
- Prevalence Study of Gastrointestinal Risk Factors in Patients With Osteoarthritis (OA), Rheumatoid Arthritis (RA) and Ankylosing Spondylitis (AS).CompletedNCT01577563
- Assessment of NSAID-treated Patients Adherence to Co-prescribed Proton Pump Inhibitor (PPI)CompletedNCT01519375
- Descriptive Study in Patients Treated With Vimovo™, Including Registration of the Physicians' Prescribing PatternsCompletedNCT01511926
- Effects of Administration of Fostamatinib on Blood Concentrations of Digoxin in Healthy SubjectsCompletedNCT01355354Phase 1
- Effects of Administration of Fostamatinib on Blood Concentrations of Rifampicin in Healthy Subjects.CompletedNCT01336218Phase 1
- Effects of Administration of Fostamatinib on Blood Concentrations of Warfarin in Healthy SubjectsCompletedNCT01311622Phase 1
- Effects of Administration of Fostamatinib on Blood Concentrations of Pioglitazone in Healthy SubjectsCompletedNCT01309854Phase 1
- Effects of Administration of Fostamatinib on Blood Concentrations of an Oral Contraceptive in Healthy Female SubjectsCompletedNCT01276262Phase 1
- A Study of Fostamatinib in Subjects With Impaired Kidney FunctionCompletedNCT01245790Phase 1
- Observational Study on Non-steroid Anti-inflammatory Drugs (NSAIDs) Treated Patients With Arthritic DisorderCompletedNCT01176682
- A Study to Assess the Pharmacokinetics of Methotrexate Given With and Without AZD9056 in Rheumatoid Arthritis PatientsWithdrawnNCT00920608Phase 1
- A Study to Investigate the Potential for AZD5672 to Affect the Electrical Conduction Pathways in the HeartCompletedNCT00887770Phase 1
- AZD5672 Bioavailability Study in Healthy Male and Female SubjectsCompletedNCT00871767Phase 1
- A Single Dose Study of the CAM-3001 in Patients With Rheumatoid ArthritisCompletedNCT00771420Phase 1
- Mass Balance and Metabolic Profiling of [14C]AZD5672 in Healthy Male VolunteersCompletedNCT00711074Phase 1
- Cross-over Study to Investigate Retinal Function Following Administration of a Single Dose of AZD9056CompletedNCT00700986Phase 1
- Effects of MEDI-522 On Disease Activity and Progression of Joint Damage in Patients With Active Rheumatoid Arthritis Suboptimally Responding to MethotrexateCompletedNCT00069017Phase 2